Home/Filings/4/0001453687-23-000018
4//SEC Filing

Kishimoto Takashi Kei 4

Accession 0001453687-23-000018

CIK 0001453687other

Filed

Jan 3, 7:00 PM ET

Accepted

Jan 4, 5:01 PM ET

Size

7.3 KB

Accession

0001453687-23-000018

Insider Transaction Report

Form 4
Period: 2023-01-02
Kishimoto Takashi Kei
Chief Scientific Officer
Transactions
  • Award

    Common Stock

    2023-01-02+100,000374,100 total
  • Award

    Employee Stock Option (right to buy)

    2023-01-02+475,000475,000 total
    Exercise: $1.13Exp: 2033-01-01Common Stock (475,000 underlying)
Footnotes (3)
  • [F1]Each Restricted Stock Unit represents a contingent right to receive one share of common stock, which will vest as to 25% on January 2, 2024. The remainder of the underlying shares will vest in three equal annual installments thereafter so that the underlying shares will be fully vested on January 2, 2027.
  • [F2]Includes 5,747 shares of common stock purchased under the Issuer's Employee Stock Purchase Program during the contribution period between September 1, 2021 and February 28, 2022.
  • [F3]This option vests as to 25% on January 2, 2024. The remainder of the underlying shares will vest in 36 equal monthly installments thereafter.

Issuer

SELECTA BIOSCIENCES INC

CIK 0001453687

Entity typeother

Related Parties

1
  • filerCIK 0001676930

Filing Metadata

Form type
4
Filed
Jan 3, 7:00 PM ET
Accepted
Jan 4, 5:01 PM ET
Size
7.3 KB